Asiatic Laboratories Limited (DSE:ASIATICLAB)

Market Cap	6.13B
Revenue (ttm)	1.47B
Net Income (ttm)	268.56M
Shares Out	122.39M
EPS (ttm)	3.06
PE Ratio	16.39
Forward PE	n/a
Dividend	1.00 (2.00%)
Ex-Dividend Date	Nov 23, 2025

Volume	465,734
Average Volume	932,433
Open	50.90
Previous Close	50.70
Day's Range	49.40 - 51.00
52-Week Range	29.00 - 65.00
Beta	n/a
RSI	38.34
Earnings Date	Feb 9, 2026

About Asiatic Laboratories

Asiatic Laboratories Limited manufactures and markets pharmaceutical products in Bangladesh and internationally. The company offers products in the categories of antihistamines and respiratory care; cardiac and eye care; antibiotics, antifungals and antiprotozoals; vitamins and minerals; antiulcerants and antiemetics; dermatological products; antipsychotics and tranquilizers; and non-steroidal anti-inflammatory drugs. It distributes its products through sales distribution centers and a store. The company also exports its products. Asiatic Labor...

• Industry: Pharmaceutical Preparations
• Founded: 1970
• Employees: 777
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ASIATICLAB

Financial Performance

In 2022, Asiatic Laboratories's revenue was 1.47 billion, an increase of 1.48% compared to the previous year's 1.45 billion. Earnings were 268.56 million, a decrease of -16.21%.